Drug Shortage Report for CLINDAMYCIN INJECTION IN 5% DEXTROSE

Last updated on 2023-11-01 History
Report ID 183714
Drug Identification Number 02485478
Brand name CLINDAMYCIN INJECTION IN 5% DEXTROSE
Common or Proper name CLINDAMYCIN INJECTION IN 5% DEXTROSE
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 600MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50mL
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2023-06-10
Actual start date 2023-06-10
Estimated end date 2023-10-31
Actual end date 2023-10-31
Shortage status Resolved
Updated date 2023-11-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-11-01 English Compare
v7 2023-10-31 French Compare
v6 2023-10-31 English Compare
v5 2023-10-02 French Compare
v4 2023-10-02 English Compare
v3 2023-06-11 English Compare
v2 2023-02-06 French Compare
v1 2023-02-06 English Compare

Showing 1 to 8 of 8